Enjoy complimentary customisation on priority with our Enterprise License!
In Europe, approximately 70% of the total population suffers from vitamin D deficiency, of which barely 5-6% has undergone vitamin D testing. This indicates that the vitamin D testing market in Europe is unpenetrated and has a high potential since the market has a large patient pool. Major vendors in Europe understand the potential market scenario and are constantly investing in R&D and innovating vitamin D testing devices, and assays and kits that will provide an accurate result at low cost.
Growing vitamin D deficiency will lead to various acute and chronic diseases such as cancer and asthma if not detected at an early stage and can be fatal for a patient. Thus, prevention of these fatal diseases is considered one of the major drivers contributing to the growth of the vitamin D testing market in Europe. Technavio expects the vitamin D testing market in Europe to grow at a steady rate, posting a CAGR of more than 5% during the forecast period.
With a massive share of 77% in 2014, the 25-hydroxy vitamin D test segment held the majority of the vitamin D testing market in Europe, and this trend is expected to continue during the forecast period. The 25-hydroxy test is the most commonly used test to detect levels of vitamin D in the body.
The European market for vitamin D appears attractive from the vendors’ perspective as a major part of the market is untapped. Therefore, there is robust competition among the vendors to develop products with high accuracy and efficiency through constant investment in R&D and innovation in the market.
Top vendors in this market are -
Other prominent vendors included in this report are SCIEX Diagnostics, Diazyme Laboratories, Biokit, City Assays, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Biorad Laboratories, Piramal Healthcare, Beckman Coulter, and Becton Dickinson.
Technavio’s market research analysts analyze upcoming trends such as the increased focus on strong scientific evidence supporting the combined use of calcium and vitamin D supplementation in the prevention of fractures, which is a commonly occurring condition due to vitamin D deficiency.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the vitamin D testing market in Europe. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Vitamin D status in Europe
PART 06: Market landscape
PART 07: Market segmentation by application
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
PART 15: Appendix
PART 16: Explore Technavio
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.